For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...
Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...
Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their Membrane Proteome Arraytm (MPA) Qualification Plan for advancement as a Drug ...
Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than N-Acetyl-L-Cysteine ("NAC ... based drugs decrease binding of SARS-CoV ...
Detailed price information for Revive Therapeutics Ltd (RVVTF) from The Globe and Mail including charting and trades.
US, COVID-19 vaccines are available for adults and children, however, the vaccination rates are low. As per the CDC data, as ...
A new reverse mutational scanning approach can detect viral mutations responsible for immune evasion in new virus variants.